These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 32711241)

  • 1. Coronavirus infection and immune system: An insight of COVID-19 in cancer patients.
    Indini A; Rijavec E; Ghidini M; Bareggi C; Cattaneo M; Galassi B; Gambini D; Grossi F
    Crit Rev Oncol Hematol; 2020 Sep; 153():103059. PubMed ID: 32711241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developing a risk assessment score for patients with cancer during the coronavirus disease 2019 pandemic.
    Indini A; Rijavec E; Ghidini M; Cattaneo M; Grossi F
    Eur J Cancer; 2020 Aug; 135():47-50. PubMed ID: 32534244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematopoietic stem cell transplantation dilemma during the COVID-19 era.
    Samaha R; Kattan J
    Future Oncol; 2020 Aug; 16(22):1569-1573. PubMed ID: 32458703
    [No Abstract]   [Full Text] [Related]  

  • 4. Coronavirus Disease 2019 (COVID-19) and Immune-Engaging Cancer Treatment.
    Abid MB; Mughal M; Abid MA
    JAMA Oncol; 2020 Oct; 6(10):1529-1530. PubMed ID: 32433719
    [No Abstract]   [Full Text] [Related]  

  • 5. COVID-19 and cancer: do we really know what we think we know?
    Robinson AG; Gyawali B; Evans G
    Nat Rev Clin Oncol; 2020 Jul; 17(7):386-388. PubMed ID: 32424196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group.
    Al-Shamsi HO; Alhazzani W; Alhuraiji A; Coomes EA; Chemaly RF; Almuhanna M; Wolff RA; Ibrahim NK; Chua MLK; Hotte SJ; Meyers BM; Elfiki T; Curigliano G; Eng C; Grothey A; Xie C
    Oncologist; 2020 Jun; 25(6):e936-e945. PubMed ID: 32243668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 infection in kidney transplant recipients.
    Banerjee D; Popoola J; Shah S; Ster IC; Quan V; Phanish M
    Kidney Int; 2020 Jun; 97(6):1076-1082. PubMed ID: 32354637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term infection of SARS-CoV-2 changed the body's immune status.
    Lin L; Luo S; Qin R; Yang M; Wang X; Yang Q; Zhang Y; Wang Q; Zhu R; Fan H; Wang H; Hu Y; Wang L; Hu D
    Clin Immunol; 2020 Sep; 218():108524. PubMed ID: 32659373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes of coronavirus disease 2019 (COVID-19) in cancer patients with prior exposure to immune checkpoint inhibitors.
    Wu Q; Chu Q; Zhang H; Yang B; He X; Zhong Y; Yuan X; Chua MLK; Xie C
    Cancer Commun (Lond); 2020 Aug; 40(8):374-379. PubMed ID: 32666636
    [No Abstract]   [Full Text] [Related]  

  • 10. Optimal Management of Acute Lymphoblastic Leukemia (ALL) in Adult Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic.
    Alhuraiji A; Eldadah S; Alfraih F; Pandita R; Absi A; Hanbali A; Aljurf M; El Fakih R
    Gulf J Oncolog; 2020 May; 1(33):7-18. PubMed ID: 32476644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer and Coronavirus Disease 2019 (COVID-19)-Facing the "C Words".
    Shah UA
    JAMA Oncol; 2020 Sep; 6(9):1330-1331. PubMed ID: 32379856
    [No Abstract]   [Full Text] [Related]  

  • 12. Immune-mediated approaches against COVID-19.
    Florindo HF; Kleiner R; Vaskovich-Koubi D; Acúrcio RC; Carreira B; Yeini E; Tiram G; Liubomirski Y; Satchi-Fainaro R
    Nat Nanotechnol; 2020 Aug; 15(8):630-645. PubMed ID: 32661375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of child immunity in the context of COVID-19 pandemic.
    Kloc M; Ghobrial RM; Kuchar E; Lewicki S; Kubiak JZ
    Clin Immunol; 2020 Aug; 217():108510. PubMed ID: 32544611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncology Care Delivery in the COVID-19 Pandemic: An Opportunity to Study Innovations and Outcomes.
    Cinar P; Cox J; Kamal A; Bickel K; Krzyzanowska M; Armitage J; Ganti AK; Ward J; Wong S; Lonial S; Bosserman L
    JCO Oncol Pract; 2020 Aug; 16(8):431-434. PubMed ID: 32463764
    [No Abstract]   [Full Text] [Related]  

  • 15. Cancer Patients and Risk of Mortality for COVID-19.
    Curigliano G
    Cancer Cell; 2020 Aug; 38(2):161-163. PubMed ID: 32710820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active and Effective Measures for the Care of Patients With Cancer During the COVID-19 Spread in China.
    Wang Z; Wang J; He J
    JAMA Oncol; 2020 May; 6(5):631-632. PubMed ID: 32236504
    [No Abstract]   [Full Text] [Related]  

  • 17. Immune checkpoint blockade: releasing the breaks or a protective barrier to COVID-19 severe acute respiratory syndrome?
    Pickles OJ; Lee LYW; Starkey T; Freeman-Mills L; Olsson-Brown A; Cheng V; Hughes DJ; Lee A; Purshouse K; Middleton G
    Br J Cancer; 2020 Sep; 123(5):691-693. PubMed ID: 32546835
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Bao R; Hernandez K; Huang L; Luke JJ
    J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32675312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer Treatment Adaptations in the COVID-19 Era.
    Waisberg F; Enrico D; Angel M; Chacón M
    JCO Oncol Pract; 2020 Jun; 16(6):305-307. PubMed ID: 32324487
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of Febrile Neutropenia Associated With SARS-CoV-2 Infection in a Patient With Cancer.
    Figuero-Pérez L; Olivares-Hernández A; Escala-Cornejo RA; Cruz-Hernández JJ
    JCO Oncol Pract; 2020 Jun; 16(6):348-349. PubMed ID: 32369410
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.